Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Multicenter Study
. 2010 May;156(5):704-10, 710.e1-710.e2.
doi: 10.1016/j.jpeds.2009.11.061. Epub 2010 Feb 10.

Antithrombotic treatment in neonatal cerebral sinovenous thrombosis: results of the International Pediatric Stroke Study

Collaborators, Affiliations
Multicenter Study

Antithrombotic treatment in neonatal cerebral sinovenous thrombosis: results of the International Pediatric Stroke Study

Lori C Jordan et al. J Pediatr. 2010 May.

Abstract

Objective: To identify predictors of antithrombotic treatment in neonates with cerebral sinovenous thrombosis (CSVT) in a large multinational study.

Study design: Neonates with CSVT from 10 countries were enrolled in the International Pediatric Stroke Study from 2003 through 2007. Term neonates with CSVT who presented with neurologic symptoms or signs of systemic illness and neuroimaging evidence of thrombus or flow interruption within cerebral venous system were included.

Results: Of 341 neonates enrolled, 84 had isolated CSVT. Neuroimaging findings, available in 67/84 neonates, included venous ischemic infarction in 5, hemorrhagic infarction or other intracranial hemorrhage in 13, both infarction and hemorrhage in 26, and no parenchymal lesions in 23. Treatment data, available in 81/84 neonates, included antithrombotic medications in 52% (n = 43), comprising heparin (n = 14), low molecular weight heparin (n = 34), warfarin (n = 1), and aspirin (n = 2). By univariate logistic regression analysis, deep venous system thrombosis (P = .05) and location in the United States (P = .001) predicted nontreatment. Presence of infarction, hemorrhage, dehydration, systemic illness, and age did not predict treatment or nontreatment. In multivariate analysis only geographic location remained significant.

Conclusions: In neonatal CSVT, regional antithrombotic treatment practices demonstrate considerable variability and uncertainty about indications for antithrombotic therapy. Additional studies are warranted.

PubMed Disclaimer

Figures

Figure 1 (A-D)
Figure 1 (A-D). MRI of the brain in neonatal cerebral sinovenous thrombosis
A) Sagittal T1 image showing hyperintense signal abnormality, suggestive of clot in the superior sagittal and straight sinus (arrowheads) B) Axial T2 image showing signal abnormalities in the bilateral frontal white matter suggestive of hemorrhagic transformation of ischemic infarcts (indicated by asterisks). Similarly, there is hemorrhage in the medial thalamus (arrowheads), suggestive of thrombosis in the deep venous system C) Diffusion-weighted sequence reveals restricted diffusion in bilateral frontal subcortical regions (asterisks), confirming ischemic infarction and hemorrhage in the medial thalamus (arrowheads) D) Gadolinium-enhanced coronal image shows filling defects in superior sagittal sinus (arrowheads), confirming clot in this region.

Comment in

  • Neonatal cerebral venous thrombosis: le debut.
    Massicotte MP, Bousser MG, Bauman ME. Massicotte MP, et al. J Pediatr. 2010 May;156(5):695-6. doi: 10.1016/j.jpeds.2010.01.004. Epub 2010 Mar 16. J Pediatr. 2010. PMID: 20236660 No abstract available.

Similar articles

Cited by

References

    1. Monagle P, Chan A, Massicotte P, Chalmers E, Michelson AD. Antithrombotic therapy in children: The seventh ACCP conference on antithrombotic and thrombolytic therapy. Chest. 2004;126(3 Suppl):645S–87S. - PubMed
    1. Monagle P, Chalmers E, Chan A, DeVeber G, Kirkham F, Massicotte P, et al. Antithrombotic therapy in neonates and children: American college of chest physicians evidence-based clinical practice guidelines (8th edition). Chest. 2008;133(6 Suppl):887S–968S. - PubMed
    1. Roach ES, Golomb MR, Adams R, Biller J, Daniels S, Deveber G, et al. Management of stroke in infants and children: A scientific statement from a special writing group of the american heart association stroke council and the council on cardiovascular disease in the young. Stroke. 2008;39:2644–91. - PubMed
    1. deVeber G, Andrew M, Adams C, Bjornson B, Booth F, Buckley DJ, et al. Cerebral sinovenous thrombosis in children. N Engl J Med. 2001;345:417–23. - PubMed
    1. Kenet G, Kirkham F, Niederstadt T, Heinecke A, Saunders D, Stoll M, Brenner B, Bidlingmaier C, Heller C, Knöfler R, Schobess R, Zieger B, Sébire G, Nowak-Göttl U, European Thromboses Study Group Risk factors for recurrent venous thromboembolism in the European collaborative paediatric database on cerebral venous thrombosis: a multicentre cohort study. Lancet Neurol. 2007;6:595–603. - PMC - PubMed

Publication types

MeSH terms